Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

[Gastric metastasis of merkel cell carcinoma: Review of the literature and histopathological differential diagnoses].

Tauziède-Espariat A, Couvelard A, Raffoul J, Monnin C, Lassabe C, Sun SR.

Ann Pathol. 2019 Dec 16. pii: S0242-6498(19)30183-X. doi: 10.1016/j.annpat.2019.11.002. [Epub ahead of print] French. No abstract available.

PMID:
31859065
2.

[Acinic cell carcinoma: an unsuspected malignancy of the nasal cavity].

Nassereddine H, Cristofari JP, Halimi C, Couvelard A, Guyard A, Hourseau M.

Ann Pathol. 2019 Dec 10. pii: S0242-6498(19)30184-1. doi: 10.1016/j.annpat.2019.11.003. [Epub ahead of print] French.

PMID:
31836252
3.

hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status.

Raffenne J, Nicolle R, Puleo F, Le Corre D, Boyez C, Marechal R, Emile JF, Demetter P, Bardier A, Laurent-Puig P, de Mestier L, Paradis V, Couvelard A, VanLathem JL, MacKey JR, Bachet JB, Svrcek M, Cros J.

Cancers (Basel). 2019 Nov 18;11(11). pii: E1808. doi: 10.3390/cancers11111808.

4.

Chemotherapy in resected neuroendocrine carcinomas of the digestive tract: a national study from the French Group of Endocrine Tumours (GTE).

Pellat A, Walter T, Augustin J, Hautefeuille V, Hentic O, Do Cao C, Lièvre A, Coriat R, Hammel P, Dubreuil O, Cohen R, Couvelard A, André T, Svrcek M, Baudin E, Afchain P.

Neuroendocrinology. 2019 Aug 21. doi: 10.1159/000502825. [Epub ahead of print]

PMID:
31430756
5.

Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma.

Nassereddine H, Sannier A, Brosseau S, Rodier JM, Khalil A, Msika S, Danel C, Couvelard A, Théou-Anton N, Cazes A.

Pathol Oncol Res. 2019 Aug 12. doi: 10.1007/s12253-019-00713-1. [Epub ahead of print]

PMID:
31407221
6.

Lesion-by-lesion correlation between uptake at FDG PET and the Ki67 proliferation index in resected pancreatic neuroendocrine tumors.

de Mestier L, Armani M, Cros J, Hentic O, Rebours V, Cadiot G, Sauvanet A, Couvelard A, Lebtahi R, Ruszniewski P.

Dig Liver Dis. 2019 Dec;51(12):1720-1724. doi: 10.1016/j.dld.2019.06.022. Epub 2019 Jul 23.

PMID:
31350186
7.

Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors.

de Mestier L, Lorenzo D, Fine C, Cros J, Hentic O, Walter T, Panis Y, Couvelard A, Cadiot G, Ruszniewski P.

Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101293. doi: 10.1016/j.beem.2019.101293. Epub 2019 Jul 9. Review.

PMID:
31326374
8.

Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis.

Quilichini E, Fabre M, Dirami T, Stedman A, De Vas M, Ozguc O, Pasek RC, Cereghini S, Morillon L, Guerra C, Couvelard A, Gannon M, Haumaitre C.

Cell Mol Gastroenterol Hepatol. 2019;8(3):487-511. doi: 10.1016/j.jcmgh.2019.06.005. Epub 2019 Jun 21.

9.

Astaxanthin Complexes to Attenuate Muscle Damage after In Vivo Femoral Ischemia-Reperfusion.

Zuluaga Tamayo M, Choudat L, Aid-Launais R, Thibaudeau O, Louedec L, Letourneur D, Gueguen V, Meddahi-Pellé A, Couvelard A, Pavon-Djavid G.

Mar Drugs. 2019 Jun 14;17(6). pii: E354. doi: 10.3390/md17060354.

10.

Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells.

Collet L, Ghurburrun E, Meyers N, Assi M, Pirlot B, Leclercq IA, Couvelard A, Komuta M, Cros J, Demetter P, Lemaigre FP, Borbath I, Jacquemin P.

Gut. 2019 Jun 1. pii: gutjnl-2018-318059. doi: 10.1136/gutjnl-2018-318059. [Epub ahead of print]

PMID:
31154393
11.

[Bilateral adrenal tumors].

Esnault H, Lahaye C, Girard L, Desoutter MA, Couvelard A, Alexandra JF, Faucher N, Raynaud-Simon A, Lilamand M, Sanchez M.

Rev Med Interne. 2020 Jan;41(1):62-64. doi: 10.1016/j.revmed.2019.04.012. Epub 2019 May 24. French. No abstract available.

PMID:
31133331
12.

Risk of Perforated Colonic Diverticulitis in Patients With Chronic Kidney Disease Requiring Sodium Polystyrene Sulfonate: Not to Be Forgotten.

Nassereddine H, Pelletier AL, Chemouny JM, Rebibo L, Vrtovsnik F, Msika S, Couvelard A, Sannier A.

Am J Gastroenterol. 2019 Jun;114(6):1003-1005. doi: 10.14309/ajg.0000000000000276. No abstract available.

PMID:
31107688
13.

Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis.

Prignon A, Provost C, Alshoukr F, Wendum D, Couvelard A, Barbet J, Forgez P, Talbot JN, Gruaz-Guyon A.

Mol Pharm. 2019 Jun 3;16(6):2776-2784. doi: 10.1021/acs.molpharmaceut.9b00283. Epub 2019 May 3.

PMID:
31013092
14.

Non-branched microcysts of the pancreas on MR imaging of patients with pancreatic tumors who had pancreatectomy may predict the presence of pancreatic intraepithelial neoplasia (PanIN): a preliminary study.

Vullierme MP, Menassa L, Couvelard A, Rebours V, Maire F, Ibrahim T, Cros J, Ruszniewski P, Sauvanet A, Levy P, Soyer P, Vilgrain V.

Eur Radiol. 2019 Nov;29(11):5731-5741. doi: 10.1007/s00330-019-06154-3. Epub 2019 Apr 10.

PMID:
30972547
15.

O6-methylguanine-DNA methyltransferase (MGMT) status in neuroendocrine tumors: a randomized phase II study (MGMT-NET).

Lemelin A, Barritault M, Hervieu V, Payen L, Péron J, Couvelard A, Cros J, Scoazec JY, Bin S, Villeneuve L, Lombard-Bohas C, Walter T; MGMT-NET investigators.

Dig Liver Dis. 2019 Apr;51(4):595-599. doi: 10.1016/j.dld.2019.02.001. Epub 2019 Feb 14.

PMID:
30824408
16.

Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset.

Nicolle R, Raffenne J, Paradis V, Couvelard A, de Reynies A, Blum Y, Cros J.

Cancers (Basel). 2019 Jan 21;11(1). pii: E126. doi: 10.3390/cancers11010126.

17.

Obesity-induced pancreatopathy in rats is reversible after bariatric surgery.

Rebours V, Garteiser P, Ribeiro-Parenti L, Cavin JB, Doblas S, Pagé G, Bado A, Couvineau A, Ruszniewski P, Paradis V, Le Gall M, Van Beers BE, Couvelard A.

Sci Rep. 2018 Nov 2;8(1):16295. doi: 10.1038/s41598-018-34515-3.

18.

The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role.

Couvineau A, Dayot S, Nicole P, Gratio V, Rebours V, Couvelard A, Voisin T.

Front Endocrinol (Lausanne). 2018 Sep 27;9:573. doi: 10.3389/fendo.2018.00573. eCollection 2018. Review.

19.

Sensing of red blood cells with decreased membrane deformability by the human spleen.

Safeukui I, Buffet PA, Deplaine G, Perrot S, Brousse V, Sauvanet A, Aussilhou B, Dokmak S, Couvelard A, Cazals-Hatem D, Mercereau-Puijalon O, Milon G, David PH, Mohandas N.

Blood Adv. 2018 Oct 23;2(20):2581-2587. doi: 10.1182/bloodadvances.2018024562.

20.

Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.

Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, Caplin M, Couvelard A, Cros J, de Herder WW, Delle Fave G, Doglioni C, Federspiel B, Fischer L, Fusai G, Gavazzi F, Hansen CP, Inzani F, Jann H, Komminoth P, Knigge UP, Landoni L, La Rosa S, Lawlor RT, Luong TV, Marinoni I, Panzuto F, Pape UF, Partelli S, Perren A, Rinzivillo M, Rubini C, Ruszniewski P, Scarpa A, Schmitt A, Schinzari G, Scoazec JY, Sessa F, Solcia E, Spaggiari P, Toumpanakis C, Vanoli A, Wiedenmann B, Zamboni G, Zandee WT, Zerbi A, Falconi M.

Neuroendocrinology. 2018;107(4):375-386. doi: 10.1159/000494355. Epub 2018 Oct 9.

21.

Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms.

Jensen RT, Bodei L, Capdevila J, Couvelard A, Falconi M, Glasberg S, Kloppel G, Lamberts S, Peeters M, Rindi G, Rinke A, Rothmund M, Sundin A, Welin S, Fazio N; The ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):26-36. doi: 10.1159/000494258. Epub 2018 Oct 3. Review.

22.

Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A.

Messal N, Fernandez N, Dayot S, Gratio V, Nicole P, Prochasson C, Chantret I, LeGuilloux G, Jarry A, Couvelard A, Tréton X, Voisin T, Ogier-Denis E, Couvineau A.

Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864(11):3618-3628. doi: 10.1016/j.bbadis.2018.08.023. Epub 2018 Aug 18.

23.

Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.

Ramage JK, Valle JW, Nieveen van Dijkum EJM, Sundin A, Pascher A, Couvelard A, Kloeppel G; the ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):45-53. doi: 10.1159/000493767. Epub 2018 Sep 16. Review.

PMID:
30219817
24.

Predicting the efficacy of surgery for pain relief in patients with alcoholic chronic pancreatitis.

Bordaçahar B, Couvelard A, Vullierme MP, Bucchini L, Sauvanet A, Dokmak S, Ruszniewski P, Lévy P, Rebours V.

Surgery. 2018 Nov;164(5):1064-1070. doi: 10.1016/j.surg.2018.05.025. Epub 2018 Jul 18.

PMID:
30029988
25.

An atypical persistent eruption of adult-onset Still's disease with neutrophilic urticarial dermatosis-like dermal features: A case report and review of the literature.

Nassereddine H, Fite C, Kottler D, Descamps V, Couvelard A, Marot L, Deschamps L.

J Cutan Pathol. 2018 Oct;45(10):793-799. doi: 10.1111/cup.13320. Epub 2018 Aug 3. Review. No abstract available.

PMID:
29992610
26.

Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58.

Mariaggi AA, Péré H, Perrier M, Visseaux B, Collin G, Veyer D, Le Hingrat Q, Ferré VM, Joly V, Couvelard A, Bucau M, Davitian C, Descamps D, Abramowitz L, Charpentier C.

J Infect Dis. 2018 Aug 24;218(7):1027-1036. doi: 10.1093/infdis/jiy287.

PMID:
29788374
27.

Peritoneal Pulse Granulomas With Spiral Bodies Mimicking Peritoneal Carcinomatosis: A Case Report.

Nassereddine H, Poté N, Tammaro P, Couvelard A.

Int J Surg Pathol. 2018 Sep;26(6):561-563. doi: 10.1177/1066896918761234. Epub 2018 Mar 13.

PMID:
29529891
28.

Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.

Pellat A, Dreyer C, Couffignal C, Walter T, Lombard-Bohas C, Niccoli P, Seitz JF, Hentic O, André T, Coriat R, Faivre S, Zappa M, Ruszniewski P, Pote N, Couvelard A, Raymond E.

Neuroendocrinology. 2018;107(1):24-31. doi: 10.1159/000487237. Epub 2018 Mar 8.

PMID:
29518779
29.

In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma.

Dayot S, Speisky D, Couvelard A, Bourgoin P, Gratio V, Cros J, Rebours V, Sauvanet A, Bedossa P, Paradis V, Ruszniewski P, Couvineau A, Voisin T.

Oncotarget. 2018 Jan 9;9(6):6952-6967. doi: 10.18632/oncotarget.24084. eCollection 2018 Jan 23.

30.

Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos).

Palazzo M, Napoléon B, Gincul R, Pioche M, Pujol B, Lefort C, Fumex F, Hautefeuille V, Fabre M, Cros J, Felce M, Couvelard A, Sauvanet A, Lévy P, Ruszniewski P, Palazzo L.

Gastrointest Endosc. 2018 Jun;87(6):1481-1488. doi: 10.1016/j.gie.2017.12.033. Epub 2018 Jan 8.

PMID:
29325706
31.

[Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future].

Scoazec JY, Couvelard A; Réseau TENpath.

Ann Pathol. 2017 Dec;37(6):444-456. doi: 10.1016/j.annpat.2017.10.003. Epub 2017 Nov 21. French.

PMID:
29169836
32.

Thymic function is a major determinant of onset of antibody-mediated rejection in heart transplantation.

Sannier A, Stroumza N, Caligiuri G, Le Borgne-Moynier M, Andreata F, Senemaud J, Louedec L, Even G, Gaston AT, Deschildre C, Couvelard A, Ou P, Cheynier R, Nataf P, Dorent R, Nicoletti A.

Am J Transplant. 2018 Apr;18(4):964-971. doi: 10.1111/ajt.14595. Epub 2017 Dec 23.

33.

[A paratesticular nodule].

Guyard A, Sannier A, Grassano Y, Choudat L, Couvelard A, Hourseau M.

Ann Pathol. 2017 Dec;37(6):492-494. doi: 10.1016/j.annpat.2017.10.009. Epub 2017 Nov 15. Review. French. No abstract available.

PMID:
29153387
34.

[A rare endolaryngeal tumor].

Ngo C, Albert S, Barry B, Copie-Bergman C, Couvelard A, Hourseau M.

Ann Pathol. 2017 Oct;37(5):420-424. doi: 10.1016/j.annpat.2017.06.025. Epub 2017 Sep 28. Review. French.

PMID:
28964599
35.

18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation.

Bucau M, Laurent-Bellue A, Poté N, Hentic O, Cros J, Mikail N, Rebours V, Ruszniewski P, Lebtahi R, Couvelard A.

Neuroendocrinology. 2018;106(3):274-282. doi: 10.1159/000480239. Epub 2017 Aug 11.

PMID:
28803235
36.

Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P.

Neuroendocrinology. 2017;105(4):412-425. doi: 10.1159/000475527. Epub 2017 Aug 12. Review.

37.

Tumor Heterogeneity in Pancreatic Adenocarcinoma.

Cros J, Raffenne J, Couvelard A, Poté N.

Pathobiology. 2018;85(1-2):64-71. doi: 10.1159/000477773. Epub 2017 Aug 5. Review.

38.

Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis.

Chuvin N, Vincent DF, Pommier RM, Alcaraz LB, Gout J, Caligaris C, Yacoub K, Cardot V, Roger E, Kaniewski B, Martel S, Cintas C, Goddard-Léon S, Colombe A, Valantin J, Gadot N, Servoz E, Morton J, Goddard I, Couvelard A, Rebours V, Guillermet J, Sansom OJ, Treilleux I, Valcourt U, Sentis S, Dubus P, Bartholin L.

Cell Mol Gastroenterol Hepatol. 2017 May 31;4(2):263-282. doi: 10.1016/j.jcmgh.2017.05.005. eCollection 2017 Sep.

39.

A gastric MANEC with an adenocarcinoma of fundic-gland type as exocrine component.

Nassereddine H, Poté N, Théou-Anton N, Lamoureux G, Fléjou JF, Couvelard A.

Virchows Arch. 2017 Nov;471(5):673-678. doi: 10.1007/s00428-017-2178-z. Epub 2017 Jun 26. No abstract available.

PMID:
28653202
40.

Xanthomatous Posttraumatic Fibro-Osseous Lesion of the Rib: A Rare and Underrecognized Entity. Case Report and Literature Review.

Nassereddine H, Larousserie F, Campagna R, Castier Y, Couvelard A, Choudat L, Sannier A.

Int J Surg Pathol. 2017 Oct;25(7):640-643. doi: 10.1177/1066896917712455. Epub 2017 Jun 4. Review.

PMID:
28580818
41.

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers.

Oberg K, Couvelard A, Delle Fave G, Gross D, Grossman A, Jensen RT, Pape UF, Perren A, Rindi G, Ruszniewski P, Scoazec JY, Welin S, Wiedenmann B, Ferone D; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):201-211. doi: 10.1159/000472254. Epub 2017 Apr 8. No abstract available.

42.

Antisecretory Effects of Chimeric Somatostatin/Dopamine Receptor Ligands on Gastroenteropancreatic Neuroendocrine Tumors.

Couvelard A, Pélaprat D, Dokmak S, Sauvanet A, Voisin T, Couvineau A, Ruszniewski P.

Pancreas. 2017 May/Jun;46(5):631-638. doi: 10.1097/MPA.0000000000000813.

PMID:
28375946
43.

Long-Term Evaluation of Biliary Reflux After Experimental One-Anastomosis Gastric Bypass in Rats.

Bruzzi M, Duboc H, Gronnier C, Rainteau D, Couvelard A, Le Gall M, Bado A, Chevallier JM.

Obes Surg. 2017 Apr;27(4):1119-1122. doi: 10.1007/s11695-017-2577-x.

PMID:
28205007
44.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification.

Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, Gorbounova V, Gross D, Grossma A, Jense RT, Kulke M, Oeberg K, Rindi G, Sorbye H, Welin S; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):196-200. doi: 10.1159/000457956. Epub 2017 Feb 11. No abstract available.

45.

Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).

Roquin G, Baudin E, Lombard-Bohas C, Cadiot G, Dominguez S, Guimbaud R, Niccoli P, Legoux JL, Mitry E, Rohmer V, Ruszniewski P, Walter T, Ducreux M, Couvelard A, Scoazec JY, Ramond-Roquin A, Caroli-Bosc FX, Hentic O.

Neuroendocrinology. 2018;106(1):38-46. doi: 10.1159/000457955. Epub 2017 Feb 3.

46.

Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice.

Blais A, Drouin G, Chaumontet C, Voisin T, Couvelard A, Even PC, Couvineau A.

PLoS One. 2017 Jan 13;12(1):e0169908. doi: 10.1371/journal.pone.0169908. eCollection 2017.

47.

Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer.

Quemener C, Baud J, Boyé K, Dubrac A, Billottet C, Soulet F, Darlot F, Dumartin L, Sire M, Grepin R, Daubon T, Rayne F, Wodrich H, Couvelard A, Pineau R, Schilling M, Castronovo V, Sue SC, Clarke K, Lomri A, Khatib AM, Hagedorn M, Prats H, Bikfalvi A.

Cancer Res. 2016 Nov 15;76(22):6507-6519. doi: 10.1158/0008-5472.CAN-15-2864. Epub 2016 Sep 9.

48.

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.

Gilles ME, Maione F, Cossutta M, Carpentier G, Caruana L, Di Maria S, Houppe C, Destouches D, Shchors K, Prochasson C, Mongelard F, Lamba S, Bardelli A, Bouvet P, Couvelard A, Courty J, Giraudo E, Cascone I.

Cancer Res. 2016 Dec 15;76(24):7181-7193. Epub 2016 Oct 17.

49.

Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.

Lotfalizadeh E, Ronot M, Wagner M, Cros J, Couvelard A, Vullierme MP, Allaham W, Hentic O, Ruzniewski P, Vilgrain V.

Eur Radiol. 2017 Apr;27(4):1748-1759. doi: 10.1007/s00330-016-4539-4. Epub 2016 Aug 19.

PMID:
27543074
50.

Professional Practices and Diagnostic Issues in Neuroendocrine Tumour Pathology: Results of a Prospective One-Year Survey among French Pathologists (the PRONET Study).

Scoazec JY, Couvelard A, Monges G, Guyétant S, Bisot-Locard S, Parot X, Lepage C; PRONET Study Group.

Neuroendocrinology. 2017;105(1):67-76. doi: 10.1159/000448431. Epub 2016 Jul 21.

PMID:
27442514

Supplemental Content

Loading ...
Support Center